Breaking News

The company had $1.1 million in revenue during the quarter, a 10 percent increase year over year despite what the firm said was a 15 to 20 percent sales reduction due to recent hurricanes.

Though revenues from its non-invasive heart transplant rejection test AlloMap fell about 5 percent, CareDx is already being reimbursed by Medicare for its new AlloSure test.

In a study involving almost 23,000 women, DNA reflex testing detect 95 percent of trisomies while avoiding recalls. 

Analytics vendor Cota will classify records from Memorial Sloan Kettering in hopes of improving cancer care and research.

By sequencing Vibrio cholerae isolates from Africa and Latin America, investigators got a look at the lineages leading to outbreaks over several decades.

An Institut Pasteur-led team genotyped various Pakistani populations to reconstruct the genetic history of descendants of the Indian Ocean slave trade.

The robotic microbial DNA isolation and direct PCR test is designed for routine bacterial and fungal pathogen diagnosis.

The next-generation sequencing-based multiplex assay screens 120 hotspots and 17 exons in 33 known cancer genes.

GeneNews said that it has decided to make an initial draw down of $500,000 to help "fuel the company's momentum while minimizing dilution."

A genome-wide association study meta-analysis found bipolar disorder patients with poor response to lithium have more polygenic risk factors for schizophrenia.

The revenue increase was primarily driven by increased revenue in the company's biopharma services, clinical services, and discovery services divisions.

The firm saw a 6 percent increase in fiscal fourth quarter revenues, with growth in both its diagnostics and life science segments.

The partnership will focus on examining inflamed tissue samples for mortality-causing pathogens through ReadCoor's fluorescent in-situ sequencing platform.

The molecular diagnostics company reported total revenues of $56.7 million in the quarter, and saw its testing volume grow 15 percent over Q3 2016.

The firm's 14 percent growth in molecular diagnostics sales was driven primarily by continued strength across its Aptima women's health products globally.

Test volume was up 5 percent, but the company's total revenue of $83.8 million was negatively affected by hurricanes in the US, company executives said.

Labcyte and the University of Helsinki's Institute for Molecular Medicine Finland have expanded their partnership to include multiple new applications.

Using Neolithic and Chalcolithic period samples, researchers explored farming and hunter-gatherer admixture in populations from Hungary, Spain, and Germany.

Broad Institute researchers performed RNA-sequencing of 53,000 individual mouse gut epithelial cells to develop and examine expression signatures.

The German firm grew revenues to €5.3 million for the first nine months of the year from €976,000 a year ago, but its net loss expanded 48 percent year over year. 

FDNA's technology uses facial analysis, deep learning, and AI to evaluate symptoms of patients with rare genetic diseases and suggest possible diagnoses.

The Irving, Texas-based company claims that three of Foundation Medicine's cancer molecular profiling tests infringe five of its US patents.

The sequencing-based panel runs on the firm's Sentosa workflow and detects genomic mutations in the HIV virus.

Earlier this year, Rosetta effected a 1-for-12 reverse stock split after failing to meet the Nasdaq's $1 minimum bid price requirement.

Third quarter growth was driven by a sharp increase in revenues from HTG Molecular's pharmaceutical partners.

Pages

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.